On December 18, 2023, Impel Pharmaceuticals Inc. appointed Brandon Smith as the Company's Chief Restructuring Officer (CRO). Mr. Smith has served as a Senior Managing Director at Teneo Capital LLC (Teneo) since April 2023. Prior to Teneo, Mr. Smith served as a Managing Director at Ernst & Young LLP from March 2020 to March 2023 and as a Partner at CR3 Partners LLC from October 2016 to March 2020.

He earned an M.B.A. from Rice University and a B.S. from Louisiana State University.